Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-07-08 | Amended | $4,000,032 | $2,000,016 | Equity Only | 06b | SEC link |
2025-02-18 | New | $2,000,016 | $2,000,016 | Equity Only | 06b | SEC link |
2023-03-10 | Amended | $1,166,927 | $1,069,944 | Equity Only | 06b | SEC link |
2022-12-27 | New | $96,983 | $96,983 | Equity Only | 06b | SEC link |
2022-08-10 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
2019-06-21 | New | $1,368,400 | $1,368,400 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Che Myong Jay Ko | Director, Executive |
Byron Alexandrovich Wittenberg | Director, Executive |